3D visualization of (A) interaction of urticin A with amino acids residues of the active site of COX-2 inhibitor and (B) celecoxib compatible conformation (yellow molecule) and urticin A (purple molecule)

 
 
  Part of: Vyshnevska L, Severina HI, Prokopenko Y, Shmalko A (2022) Molecular docking investigation of anti-inflammatory herbal compounds as potential LOX-5 and COX-2 inhibitors. Pharmacia 69(3): 733-744. https://doi.org/10.3897/pharmacia.69.e89400